Cytoprotective APC pathway

The cytoprotective APC pathway. This figure provides an overview of the direct cytoprotective effects for anti-inflammatory and anti-apoptotic activity on leukocytes and endothelial cells. The anti-inflammatory effects of APC on endothelial cells include the inhibition of NF-κB activation with decreased expression of endothelial adhesion molecules and the reduced expression of pro-inflammatory cytokines. APC also inhibits the NF-κB and AP-1 transcription factors on leukocytes and reduces their production of pro-inflammatory mediators. The end result of these effects is a reduction in leukocyte chemotaxis and infiltration. APC exerts anti-apoptotic effects on both leukocytes and endothelial cells by reducing several pro-apoptotic signals. The direct protective effects of APC on endothelial cells are mediated in the presence of EPCR and PAR-1. The effects of APC on leukocytes are mediated by EPCR alone or in the presence of PAR-1. APC increases endothelial production of PGI2 and MCP-1. The role of sEPCR, which is up-regulated in different inflammatory diseases, and PR3 on activated neutrophils are still not completely understood. PR3 binds both sEPCR and membrane-bound EPCR and may play a role in binding APC to neutrophils and/or inactivating the protein C pathway. The exact mechanism of APC signalling through PAR-1 is still not clear, and different models have been described in literature. AP-1, activator protein-1; APC, activated protein C; EPCR, endothelial protein C receptor; ICAM-1, intercellular adhesion molecule-1; IL, interleukin; MCP-1, monocyte chemoattractant protein-1; NF-κB, nuclear factor-kappa B; PAR-1, protease-activated receptor-1; PGI2, prostaglandin I2; PR3, proteinase-3; sEPCR, soluble EPCR; TNF-α, tumour necrosis factor alpha; VCAM-1, vascular cell adhesion molecule-1.
Cytoprotective APC pathway

Publication

Protective mechanisms of activated protein C in severe inflammatory disorders. (2009) Arne P Neyrinck, et al. Br J Pharmacol. 2009 Oct;158(4):1034-1047. Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates PR3 PR3 ncbigene_synonym PRTN3 5657
Homo sapiens Primates EPCR EPCR ncbigene_synonym PROCR 10544
Homo sapiens Primates NF-KB NF-KB ncbigene_synonym NFKB1 4790
Homo sapiens Primates (APC) APC ncbigene_symbol APC 324
Homo sapiens Primates (APC) APC ncbigene_synonym PROC 5624
Homo sapiens Primates AP-1 AP-1 ncbigene_synonym FOS 2353
Homo sapiens Primates AP-1 AP-1 ncbigene_synonym FOSB 2354
Homo sapiens Primates AP-1 AP-1 ncbigene_synonym JUN 3725
Homo sapiens Primates AP-1 AP-1 ncbigene_synonym JUNB 3726
Homo sapiens Primates AP-1 AP-1 ncbigene_synonym JUND 3727
Homo sapiens Primates ICAM-1 ICAM1 ncbigene_symbol ICAM1 3383
Homo sapiens Primates IL-6 IL-6 ncbigene_synonym IL6 3569
Homo sapiens Primates VCAM-1 VCAM1 ncbigene_symbol VCAM1 7412
Homo sapiens Primates IL-8 IL8 ncbigene_synonym CXCL8 3576
Homo sapiens Primates TNF-a TNF-A ncbigene_synonym TNF 7124
Homo sapiens Primates IL-18 IL-18 ncbigene_synonym IL18 3606
Homo sapiens Primates MCP-1 MCP-1 ncbigene_synonym CCL2 6347
Homo sapiens Primates PAR PAR ncbigene_synonym NR1I2 8856
Homo sapiens Primates PAR PAR ncbigene_synonym JTB 10899

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID